$2.93
-0.10 (-3.30%)
AVANIR Pharmaceuticals (NASDAQ:AVNR)
CAPS Rating:
A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.
The World's Greatest Investing Community
RSS Headlines
Fool UK
